A study for a health economist to do.
What price would people with “mild” COVID-19 pay for a theoretical cure?
Call that X. Then say you have p probability of getting the virus & q of getting seriously (“mildly”) ill.
Now the new cost of an in-person venti latte is $4.10 + Xpq
What price would people with “mild” COVID-19 pay for a theoretical cure?
Call that X. Then say you have p probability of getting the virus & q of getting seriously (“mildly”) ill.
Now the new cost of an in-person venti latte is $4.10 + Xpq
Some claim that “mild” COVID-19 isn’t worth the economic cost of avoidance.
However, if people in the throes of illness would pay (say) $10k or 10% of net worth to get well, but wouldn’t do that for a cold, that’s an economic quantification of severity.
However, if people in the throes of illness would pay (say) $10k or 10% of net worth to get well, but wouldn’t do that for a cold, that’s an economic quantification of severity.
Every study begins with a hypothesis, often based on “anecdotes”.
My hypothesis from talking to a number of COVID-19 survivors is that “mild” is actually severe for many, and that a systematic survey of patients would show us *how* many.
My hypothesis from talking to a number of COVID-19 survivors is that “mild” is actually severe for many, and that a systematic survey of patients would show us *how* many.
